

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of female gonad development (GO:2000194) | 6.42812998 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.85899902 |
| 3 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.61486918 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 4.44609042 |
| 5 | macrophage activation involved in immune response (GO:0002281) | 4.32244298 |
| 6 | activated T cell proliferation (GO:0050798) | 4.22473638 |
| 7 | microglial cell activation (GO:0001774) | 4.17496776 |
| 8 | detection of other organism (GO:0098543) | 4.11983764 |
| 9 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.03952913 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.01895728 |
| 11 | mast cell activation (GO:0045576) | 3.96188430 |
| 12 | response to interleukin-15 (GO:0070672) | 3.88420807 |
| 13 | detection of external biotic stimulus (GO:0098581) | 3.86870799 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.81883213 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81851787 |
| 16 | detection of bacterium (GO:0016045) | 3.69806202 |
| 17 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68557197 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 3.66837094 |
| 19 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.60650812 |
| 20 | regulation of RIG-I signaling pathway (GO:0039535) | 3.60021336 |
| 21 | macrophage activation (GO:0042116) | 3.60005309 |
| 22 | response to host immune response (GO:0052572) | 3.56474127 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.56474127 |
| 24 | response to peptidoglycan (GO:0032494) | 3.55143758 |
| 25 | detection of biotic stimulus (GO:0009595) | 3.50503418 |
| 26 | regulation of meiosis (GO:0040020) | 3.49640973 |
| 27 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.47249415 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.46561217 |
| 29 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.45472643 |
| 30 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.43667870 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.43091654 |
| 32 | heart contraction (GO:0060047) | 3.42927058 |
| 33 | heart process (GO:0003015) | 3.42927058 |
| 34 | female gamete generation (GO:0007292) | 3.40276316 |
| 35 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.39994798 |
| 36 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.39994798 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37011441 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37011441 |
| 39 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.36449814 |
| 40 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.31299894 |
| 41 | neutrophil mediated immunity (GO:0002446) | 3.29898409 |
| 42 | neutrophil activation (GO:0042119) | 3.29504271 |
| 43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24714937 |
| 44 | negative T cell selection (GO:0043383) | 3.24271509 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21074790 |
| 46 | response to host (GO:0075136) | 3.21074790 |
| 47 | response to host defenses (GO:0052200) | 3.21074790 |
| 48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.20230356 |
| 49 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.14319153 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.13475422 |
| 51 | sequestering of actin monomers (GO:0042989) | 3.13303481 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.13228132 |
| 53 | regulation of regulatory T cell differentiation (GO:0045589) | 3.11865921 |
| 54 | regulation of sequestering of triglyceride (GO:0010889) | 3.11682343 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.08485267 |
| 56 | positive regulation of granulocyte differentiation (GO:0030854) | 3.08378516 |
| 57 | positive T cell selection (GO:0043368) | 3.07008405 |
| 58 | megakaryocyte development (GO:0035855) | 3.06774524 |
| 59 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.06616176 |
| 60 | DNA damage induced protein phosphorylation (GO:0006975) | 3.06527088 |
| 61 | cellular response to zinc ion (GO:0071294) | 3.04762444 |
| 62 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.04615273 |
| 63 | myeloid leukocyte mediated immunity (GO:0002444) | 3.03652267 |
| 64 | myoblast migration (GO:0051451) | 3.02497241 |
| 65 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.01540837 |
| 66 | regulation of steroid hormone secretion (GO:2000831) | 3.01445294 |
| 67 | interferon-gamma production (GO:0032609) | 3.00578147 |
| 68 | mast cell degranulation (GO:0043303) | 2.99652503 |
| 69 | mast cell activation involved in immune response (GO:0002279) | 2.99652503 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95874207 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.93602481 |
| 72 | B cell receptor signaling pathway (GO:0050853) | 2.92624611 |
| 73 | granulocyte activation (GO:0036230) | 2.92087173 |
| 74 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.91972880 |
| 75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.90264708 |
| 76 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.88779846 |
| 77 | negative regulation of B cell mediated immunity (GO:0002713) | 2.88779846 |
| 78 | histone H2A ubiquitination (GO:0033522) | 2.87487402 |
| 79 | negative regulation of adaptive immune response (GO:0002820) | 2.87271283 |
| 80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85585733 |
| 81 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.83885950 |
| 82 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.83885950 |
| 83 | positive thymic T cell selection (GO:0045059) | 2.82953332 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.82419428 |
| 85 | centriole replication (GO:0007099) | 2.80519620 |
| 86 | detection of calcium ion (GO:0005513) | 2.79594833 |
| 87 | T cell migration (GO:0072678) | 2.79090794 |
| 88 | dendritic cell migration (GO:0036336) | 2.78656497 |
| 89 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.76658135 |
| 90 | negative regulation of type 2 immune response (GO:0002829) | 2.75027619 |
| 91 | positive regulation of tolerance induction (GO:0002645) | 2.74762295 |
| 92 | type B pancreatic cell development (GO:0003323) | 2.74527790 |
| 93 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.74395228 |
| 94 | positive regulation of defense response to virus by host (GO:0002230) | 2.72337150 |
| 95 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70846625 |
| 96 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.70805508 |
| 97 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69528948 |
| 98 | regulation of meiotic cell cycle (GO:0051445) | 2.69173957 |
| 99 | T cell selection (GO:0045058) | 2.69133559 |
| 100 | piRNA metabolic process (GO:0034587) | 2.68949047 |
| 101 | cellular extravasation (GO:0045123) | 2.67569635 |
| 102 | signal peptide processing (GO:0006465) | 2.67414890 |
| 103 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.65198603 |
| 104 | germinal center formation (GO:0002467) | 2.64966076 |
| 105 | regulation of T cell tolerance induction (GO:0002664) | 2.64562625 |
| 106 | oxygen transport (GO:0015671) | 2.63547209 |
| 107 | regulation of granulocyte differentiation (GO:0030852) | 2.63292121 |
| 108 | respiratory burst (GO:0045730) | 2.62610086 |
| 109 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.62603136 |
| 110 | negative regulation of meiosis (GO:0045835) | 2.62115412 |
| 111 | response to type I interferon (GO:0034340) | 2.62000781 |
| 112 | negative regulation of meiotic cell cycle (GO:0051447) | 2.61855623 |
| 113 | cellular response to virus (GO:0098586) | 2.61436910 |
| 114 | type I interferon signaling pathway (GO:0060337) | 2.61327611 |
| 115 | cellular response to type I interferon (GO:0071357) | 2.61327611 |
| 116 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.61061620 |
| 117 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.59579366 |
| 118 | positive regulation of humoral immune response (GO:0002922) | 2.58905886 |
| 119 | tolerance induction (GO:0002507) | 2.58458273 |
| 120 | dendritic cell chemotaxis (GO:0002407) | 2.58398579 |
| 121 | positive regulation of macrophage differentiation (GO:0045651) | 2.57835252 |
| 122 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.57192342 |
| 123 | positive regulation of B cell differentiation (GO:0045579) | 2.56005389 |
| 124 | hepatocyte apoptotic process (GO:0097284) | 2.55910084 |
| 125 | negative regulation of cell killing (GO:0031342) | 2.55705606 |
| 126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.55705606 |
| 127 | interkinetic nuclear migration (GO:0022027) | 2.55545441 |
| 128 | regulation of necroptotic process (GO:0060544) | 2.55001927 |
| 129 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.54869382 |
| 130 | myeloid dendritic cell activation (GO:0001773) | 2.53694720 |
| 131 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.52760270 |
| 132 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.52595499 |
| 133 | regulation of hypersensitivity (GO:0002883) | 2.51998411 |
| 134 | meiotic cell cycle (GO:0051321) | 2.51869135 |
| 135 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.51629286 |
| 136 | myeloid dendritic cell differentiation (GO:0043011) | 2.51509963 |
| 137 | cellular response to exogenous dsRNA (GO:0071360) | 2.51259546 |
| 138 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.50809480 |
| 139 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.50440114 |
| 140 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.50256164 |
| 141 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.49122234 |
| 142 | regulation of response to interferon-gamma (GO:0060330) | 2.44957752 |
| 143 | endothelium development (GO:0003158) | 2.44826411 |
| 144 | regulation of gamma-delta T cell activation (GO:0046643) | 2.43064203 |
| 145 | potassium ion export (GO:0071435) | 2.41161686 |
| 146 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.39629292 |
| 147 | leukocyte aggregation (GO:0070486) | 2.37444046 |
| 148 | regulation of macrophage differentiation (GO:0045649) | 2.34250211 |
| 149 | phosphorelay signal transduction system (GO:0000160) | 2.34147741 |
| 150 | regulation of histone phosphorylation (GO:0033127) | 2.33251500 |
| 151 | negative regulation of granulocyte differentiation (GO:0030853) | 2.31387794 |
| 152 | positive regulation of T cell apoptotic process (GO:0070234) | 2.30259525 |
| 153 | microtubule nucleation (GO:0007020) | 2.29165026 |
| 154 | regulation of B cell differentiation (GO:0045577) | 2.28264990 |
| 155 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.28117606 |
| 156 | neutrophil activation involved in immune response (GO:0002283) | 2.27510105 |
| 157 | brown fat cell differentiation (GO:0050873) | 2.27181371 |
| 158 | modulation by virus of host process (GO:0019054) | 2.27169822 |
| 159 | barbed-end actin filament capping (GO:0051016) | 2.26427056 |
| 160 | regulation of histone H3-K27 methylation (GO:0061085) | 2.25933657 |
| 161 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.24791398 |
| 162 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.24791398 |
| 163 | modulation by symbiont of host immune response (GO:0052553) | 2.24791398 |
| 164 | positive regulation by symbiont of host defense response (GO:0052509) | 2.24791398 |
| 165 | modulation by symbiont of host defense response (GO:0052031) | 2.24791398 |
| 166 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.24791398 |
| 167 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.24485049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.17472304 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.58278814 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41924680 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.34151690 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.12296523 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.07793015 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.84494032 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78427752 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.68812070 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60525230 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.56279874 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.45316555 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.40547040 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29997649 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.12725610 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12709161 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.06192663 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.98957582 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.96719317 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89816541 |
| 21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89750194 |
| 22 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81851313 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81447276 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63287629 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62419131 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.61376850 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60290262 |
| 28 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60244436 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54682606 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54431405 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49192138 |
| 32 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48923464 |
| 33 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37500790 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37272055 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36756648 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34342417 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29659707 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28339443 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28189421 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27900955 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26973175 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24187709 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21547312 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20818528 |
| 45 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20437255 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18602571 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17461911 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17042418 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16776724 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16580345 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15763659 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15519603 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14213348 |
| 54 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14067032 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13002004 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.10362183 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10172141 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09433736 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08708814 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07826064 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07549043 |
| 62 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05186553 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04760417 |
| 64 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04556538 |
| 65 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03982239 |
| 66 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03923057 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03818108 |
| 68 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03554973 |
| 69 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02400426 |
| 70 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.02361788 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00977128 |
| 72 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00421897 |
| 73 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.00215975 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99673634 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98943429 |
| 76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.98034725 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97823719 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 0.97467765 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95868533 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95861452 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95705981 |
| 82 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95466440 |
| 83 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.94791849 |
| 84 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94635043 |
| 85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94066681 |
| 86 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93740390 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93640598 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 0.93491649 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93390018 |
| 90 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92600066 |
| 91 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92498098 |
| 92 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90711979 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90389590 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90280315 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89316516 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89176565 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.88959756 |
| 98 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88408662 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.86891155 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86829320 |
| 101 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86684846 |
| 102 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.86170193 |
| 103 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85589758 |
| 104 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.85565830 |
| 105 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85563213 |
| 106 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.85385939 |
| 107 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84908305 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84607326 |
| 109 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.84552505 |
| 110 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.84546619 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84256982 |
| 112 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.83991591 |
| 113 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.83916982 |
| 114 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.83897449 |
| 115 | GATA3_26560356_Chip-Seq_TH1_Human | 0.83148826 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82936334 |
| 117 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82608859 |
| 118 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82150325 |
| 119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81571257 |
| 120 | KDM2B_26808549_Chip-Seq_REH_Human | 0.81174867 |
| 121 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80750591 |
| 122 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.80390833 |
| 123 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80366915 |
| 124 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80002477 |
| 125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.79992053 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79662796 |
| 127 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78381358 |
| 128 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78208087 |
| 129 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77681354 |
| 130 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.77109146 |
| 131 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74211599 |
| 132 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.74141152 |
| 133 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.73559754 |
| 134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73360994 |
| 135 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73270334 |
| 136 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73250825 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73152383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.64546781 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.59741896 |
| 3 | MP0003303_peritoneal_inflammation | 3.21900637 |
| 4 | MP0003724_increased_susceptibility_to | 2.91704901 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.91210176 |
| 6 | MP0005671_abnormal_response_to | 2.82971505 |
| 7 | MP0005670_abnormal_white_adipose | 2.73476993 |
| 8 | MP0009785_altered_susceptibility_to | 2.67127214 |
| 9 | MP0004510_myositis | 2.51728922 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.42770584 |
| 11 | MP0010386_abnormal_urinary_bladder | 2.14856855 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.00777372 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.00080993 |
| 14 | MP0000569_abnormal_digit_pigmentation | 1.98089447 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 1.98089096 |
| 16 | MP0005451_abnormal_body_composition | 1.97652508 |
| 17 | MP0005310_abnormal_salivary_gland | 1.90564393 |
| 18 | MP0003172_abnormal_lysosome_physiology | 1.87687184 |
| 19 | MP0000343_altered_response_to | 1.85593838 |
| 20 | MP0000685_abnormal_immune_system | 1.85178157 |
| 21 | MP0004130_abnormal_muscle_cell | 1.82465924 |
| 22 | MP0005025_abnormal_response_to | 1.79442099 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.77582490 |
| 24 | MP0003690_abnormal_glial_cell | 1.77197999 |
| 25 | MP0002419_abnormal_innate_immunity | 1.76670992 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.75404282 |
| 27 | MP0001800_abnormal_humoral_immune | 1.74830813 |
| 28 | MP0001819_abnormal_immune_cell | 1.74791477 |
| 29 | MP0001790_abnormal_immune_system | 1.74180168 |
| 30 | MP0005387_immune_system_phenotype | 1.74180168 |
| 31 | MP0002723_abnormal_immune_serum | 1.71381392 |
| 32 | MP0004215_abnormal_myocardial_fiber | 1.67333439 |
| 33 | MP0003436_decreased_susceptibility_to | 1.66971215 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.65550384 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.61362997 |
| 36 | MP0000751_myopathy | 1.59666684 |
| 37 | MP0005409_darkened_coat_color | 1.57991148 |
| 38 | MP0008260_abnormal_autophagy | 1.54500100 |
| 39 | MP0002398_abnormal_bone_marrow | 1.54355633 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.53524903 |
| 41 | MP0006292_abnormal_olfactory_placode | 1.52671601 |
| 42 | MP0003866_abnormal_defecation | 1.47178016 |
| 43 | MP0002006_tumorigenesis | 1.42520966 |
| 44 | MP0001986_abnormal_taste_sensitivity | 1.40900798 |
| 45 | MP0000716_abnormal_immune_system | 1.40221285 |
| 46 | MP0004484_altered_response_of | 1.39477781 |
| 47 | MP0002405_respiratory_system_inflammati | 1.38466958 |
| 48 | MP0002106_abnormal_muscle_physiology | 1.38162489 |
| 49 | MP0004381_abnormal_hair_follicle | 1.37813891 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.36577961 |
| 51 | MP0003828_pulmonary_edema | 1.35763651 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.34519930 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.32841791 |
| 54 | MP0002693_abnormal_pancreas_physiology | 1.32279015 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.31998377 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.31652771 |
| 57 | MP0005166_decreased_susceptibility_to | 1.30658591 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.30503207 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.29461038 |
| 60 | MP0004036_abnormal_muscle_relaxation | 1.28946079 |
| 61 | MP0003718_maternal_effect | 1.28218688 |
| 62 | MP0003075_altered_response_to | 1.28179700 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.26750050 |
| 64 | MP0001984_abnormal_olfaction | 1.25296202 |
| 65 | MP0004883_abnormal_blood_vessel | 1.25250134 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.24725957 |
| 67 | MP0001851_eye_inflammation | 1.24213485 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.23363364 |
| 69 | MP0002933_joint_inflammation | 1.23299066 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.22929549 |
| 71 | MP0002971_abnormal_brown_adipose | 1.22186897 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.20112251 |
| 73 | MP0008469_abnormal_protein_level | 1.18424782 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 1.18181016 |
| 75 | MP0000013_abnormal_adipose_tissue | 1.17656985 |
| 76 | MP0004947_skin_inflammation | 1.17647913 |
| 77 | MP0000749_muscle_degeneration | 1.16759438 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 1.13338369 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.11450419 |
| 80 | MP0003787_abnormal_imprinting | 1.10651685 |
| 81 | MP0002972_abnormal_cardiac_muscle | 1.09682436 |
| 82 | MP0000372_irregular_coat_pigmentation | 1.08813411 |
| 83 | MP0002132_abnormal_respiratory_system | 1.08547235 |
| 84 | MP0001905_abnormal_dopamine_level | 1.07998860 |
| 85 | MP0003183_abnormal_peptide_metabolism | 1.07880133 |
| 86 | MP0000689_abnormal_spleen_morphology | 1.06560320 |
| 87 | MP0002429_abnormal_blood_cell | 1.06329588 |
| 88 | MP0002638_abnormal_pupillary_reflex | 1.04327692 |
| 89 | MP0005620_abnormal_muscle_contractility | 1.03277147 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.03079949 |
| 91 | MP0002876_abnormal_thyroid_physiology | 1.02631959 |
| 92 | MP0006276_abnormal_autonomic_nervous | 1.01584533 |
| 93 | MP0002095_abnormal_skin_pigmentation | 1.01581381 |
| 94 | MP0009278_abnormal_bone_marrow | 1.01243008 |
| 95 | MP0005375_adipose_tissue_phenotype | 1.00889645 |
| 96 | MP0000703_abnormal_thymus_morphology | 1.00166265 |
| 97 | MP0001119_abnormal_female_reproductive | 0.99855656 |
| 98 | MP0010368_abnormal_lymphatic_system | 0.99754398 |
| 99 | MP0006082_CNS_inflammation | 0.99702662 |
| 100 | MP0003045_fibrosis | 0.99436831 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.99136158 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.99124374 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.98456083 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.98456083 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 0.97879205 |
| 106 | MP0001529_abnormal_vocalization | 0.97218496 |
| 107 | MP0002722_abnormal_immune_system | 0.94861139 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.93707184 |
| 109 | MP0005385_cardiovascular_system_phenoty | 0.93707184 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.93163140 |
| 111 | MP0001853_heart_inflammation | 0.91581811 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.91373153 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.91360366 |
| 114 | MP0005369_muscle_phenotype | 0.89950909 |
| 115 | MP0005646_abnormal_pituitary_gland | 0.89365840 |
| 116 | MP0009115_abnormal_fat_cell | 0.89283277 |
| 117 | MP0004084_abnormal_cardiac_muscle | 0.89200479 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.88773902 |
| 119 | MP0002102_abnormal_ear_morphology | 0.87053507 |
| 120 | MP0009764_decreased_sensitivity_to | 0.86949918 |
| 121 | MP0005164_abnormal_response_to | 0.86337666 |
| 122 | MP0004087_abnormal_muscle_fiber | 0.82902788 |
| 123 | MP0005535_abnormal_body_temperature | 0.82447756 |
| 124 | MP0008874_decreased_physiological_sensi | 0.80753378 |
| 125 | MP0003699_abnormal_female_reproductive | 0.80667604 |
| 126 | MP0005330_cardiomyopathy | 0.80445653 |
| 127 | MP0008057_abnormal_DNA_replication | 0.80054026 |
| 128 | MP0002009_preneoplasia | 0.79136953 |
| 129 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78322968 |
| 130 | MP0000858_altered_metastatic_potential | 0.71965345 |
| 131 | MP0000604_amyloidosis | 0.70934340 |
| 132 | MP0001663_abnormal_digestive_system | 0.70410043 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.64916944 |
| 134 | MP0004043_abnormal_pH_regulation | 0.64111024 |
| 135 | MP0003448_altered_tumor_morphology | 0.62939913 |
| 136 | MP0000920_abnormal_myelination | 0.61613949 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.61495922 |
| 138 | MP0008569_lethality_at_weaning | 0.60946535 |
| 139 | MP0003633_abnormal_nervous_system | 0.57469926 |
| 140 | MP0009763_increased_sensitivity_to | 0.57209886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.49219283 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.20282943 |
| 3 | Optic neuritis (HP:0100653) | 3.78810582 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 3.78810582 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.76037883 |
| 6 | Hypothermia (HP:0002045) | 3.62655503 |
| 7 | Thyroiditis (HP:0100646) | 3.48068703 |
| 8 | Male infertility (HP:0003251) | 3.45178007 |
| 9 | Orchitis (HP:0100796) | 3.40750849 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 3.19042467 |
| 11 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.17415220 |
| 12 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.17140070 |
| 13 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.04394437 |
| 14 | Abnormality of alanine metabolism (HP:0010916) | 3.04394437 |
| 15 | Hyperalaninemia (HP:0003348) | 3.04394437 |
| 16 | Gingivitis (HP:0000230) | 2.98013637 |
| 17 | Combined immunodeficiency (HP:0005387) | 2.97521400 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95081752 |
| 19 | Eczematoid dermatitis (HP:0000976) | 2.89198240 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.84488953 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 2.82637824 |
| 22 | Prolonged bleeding time (HP:0003010) | 2.77766967 |
| 23 | Hypochromic microcytic anemia (HP:0004840) | 2.76267598 |
| 24 | Abnormality of T cells (HP:0002843) | 2.74235319 |
| 25 | Gingival bleeding (HP:0000225) | 2.72486514 |
| 26 | Difficulty running (HP:0009046) | 2.70653640 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 2.69760566 |
| 28 | Spondylolisthesis (HP:0003302) | 2.69376368 |
| 29 | Atrial fibrillation (HP:0005110) | 2.68947000 |
| 30 | Recurrent viral infections (HP:0004429) | 2.66797877 |
| 31 | Recurrent skin infections (HP:0001581) | 2.62615417 |
| 32 | Papilledema (HP:0001085) | 2.61668384 |
| 33 | Episodic fever (HP:0001954) | 2.55423946 |
| 34 | Pulmonary embolism (HP:0002204) | 2.55316593 |
| 35 | Leukocytosis (HP:0001974) | 2.53997546 |
| 36 | Urticaria (HP:0001025) | 2.50822653 |
| 37 | Primary atrial arrhythmia (HP:0001692) | 2.50698477 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.50439881 |
| 39 | Oligomenorrhea (HP:0000876) | 2.49355344 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.48438671 |
| 41 | Subaortic stenosis (HP:0001682) | 2.48438671 |
| 42 | Meningitis (HP:0001287) | 2.47930980 |
| 43 | Abnormality of eosinophils (HP:0001879) | 2.45559024 |
| 44 | Muscle fiber inclusion bodies (HP:0100299) | 2.44817491 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.42204480 |
| 46 | Calf muscle hypertrophy (HP:0008981) | 2.39292829 |
| 47 | Hyporeflexia of lower limbs (HP:0002600) | 2.38649389 |
| 48 | Supraventricular tachycardia (HP:0004755) | 2.37884193 |
| 49 | Exertional dyspnea (HP:0002875) | 2.37440308 |
| 50 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.36723952 |
| 51 | Sudden death (HP:0001699) | 2.35188765 |
| 52 | Thrombocytosis (HP:0001894) | 2.35032713 |
| 53 | Lipoatrophy (HP:0100578) | 2.34848945 |
| 54 | Anorexia (HP:0002039) | 2.34281195 |
| 55 | Vasculitis (HP:0002633) | 2.33175548 |
| 56 | Arterial thrombosis (HP:0004420) | 2.31751294 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.31020749 |
| 58 | Papillary thyroid carcinoma (HP:0002895) | 2.30590569 |
| 59 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.30324437 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.30324437 |
| 61 | Nemaline bodies (HP:0003798) | 2.30079887 |
| 62 | Supraventricular arrhythmia (HP:0005115) | 2.29221984 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25782878 |
| 64 | Ventricular tachycardia (HP:0004756) | 2.25555689 |
| 65 | Abnormality of the endocardium (HP:0004306) | 2.25187840 |
| 66 | Hemiplegia (HP:0002301) | 2.24291992 |
| 67 | Abnormal hair whorl (HP:0010721) | 2.23679713 |
| 68 | Type 2 muscle fiber atrophy (HP:0003554) | 2.22985479 |
| 69 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.22768330 |
| 70 | B lymphocytopenia (HP:0010976) | 2.22403191 |
| 71 | Abnormality of B cell number (HP:0010975) | 2.22403191 |
| 72 | Muscle fiber splitting (HP:0003555) | 2.21544239 |
| 73 | Hepatic necrosis (HP:0002605) | 2.21397777 |
| 74 | Hematochezia (HP:0002573) | 2.19589758 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.18360756 |
| 76 | Abnormality of the fingertips (HP:0001211) | 2.18070607 |
| 77 | Tinnitus (HP:0000360) | 2.18038413 |
| 78 | Acute myeloid leukemia (HP:0004808) | 2.17786787 |
| 79 | Ventricular fibrillation (HP:0001663) | 2.16939656 |
| 80 | Increased muscle lipid content (HP:0009058) | 2.16001962 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.15385421 |
| 82 | Eosinophilia (HP:0001880) | 2.15384542 |
| 83 | Exercise-induced myalgia (HP:0003738) | 2.15330630 |
| 84 | Amyloidosis (HP:0011034) | 2.14893619 |
| 85 | Abnormality of macrophages (HP:0004311) | 2.14803750 |
| 86 | Hypochromic anemia (HP:0001931) | 2.14174607 |
| 87 | Nonprogressive disorder (HP:0003680) | 2.12362663 |
| 88 | Abnormality of lateral ventricle (HP:0030047) | 2.10869279 |
| 89 | Gastrointestinal infarctions (HP:0005244) | 2.10480457 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 2.10273687 |
| 91 | Slow saccadic eye movements (HP:0000514) | 2.09031295 |
| 92 | Abnormality of midbrain morphology (HP:0002418) | 2.08878453 |
| 93 | Molar tooth sign on MRI (HP:0002419) | 2.08878453 |
| 94 | Agammaglobulinemia (HP:0004432) | 2.08504929 |
| 95 | Abnormality of the fovea (HP:0000493) | 2.07653428 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.06656412 |
| 97 | Epistaxis (HP:0000421) | 2.06537951 |
| 98 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.05674810 |
| 99 | Increased IgE level (HP:0003212) | 2.04881504 |
| 100 | Gangrene (HP:0100758) | 2.02792147 |
| 101 | Palpitations (HP:0001962) | 2.02345837 |
| 102 | Myoglobinuria (HP:0002913) | 2.01076742 |
| 103 | Hypoplasia of the thymus (HP:0000778) | 2.00908091 |
| 104 | Hemoptysis (HP:0002105) | 2.00837037 |
| 105 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00319756 |
| 106 | Muscle fiber atrophy (HP:0100295) | 2.00114453 |
| 107 | Acne (HP:0001061) | 1.99392507 |
| 108 | Postural instability (HP:0002172) | 1.98502940 |
| 109 | Stomach cancer (HP:0012126) | 1.98418195 |
| 110 | Chronic diarrhea (HP:0002028) | 1.97423785 |
| 111 | Peritonitis (HP:0002586) | 1.95237039 |
| 112 | Increased CSF protein (HP:0002922) | 1.95222047 |
| 113 | Gastrointestinal stroma tumor (HP:0100723) | 1.94824250 |
| 114 | Autoimmune hemolytic anemia (HP:0001890) | 1.94631339 |
| 115 | Cerebral hemorrhage (HP:0001342) | 1.94010818 |
| 116 | Hypoplasia of the fovea (HP:0007750) | 1.93907262 |
| 117 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.93907262 |
| 118 | T lymphocytopenia (HP:0005403) | 1.93901177 |
| 119 | Left ventricular hypertrophy (HP:0001712) | 1.92959860 |
| 120 | Pulmonary fibrosis (HP:0002206) | 1.92641637 |
| 121 | Syncope (HP:0001279) | 1.92142956 |
| 122 | Generalized aminoaciduria (HP:0002909) | 1.91932933 |
| 123 | Granulocytopenia (HP:0001913) | 1.91473004 |
| 124 | Abnormality of T cell number (HP:0011839) | 1.91405495 |
| 125 | Abnormality of the pleura (HP:0002103) | 1.91308125 |
| 126 | Hepatocellular necrosis (HP:0001404) | 1.91227040 |
| 127 | Febrile seizures (HP:0002373) | 1.90937838 |
| 128 | Microcytic anemia (HP:0001935) | 1.90193051 |
| 129 | IgM deficiency (HP:0002850) | 1.90045283 |
| 130 | Encephalitis (HP:0002383) | 1.89144185 |
| 131 | Obstructive lung disease (HP:0006536) | 1.88378257 |
| 132 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88378257 |
| 133 | EMG: myopathic abnormalities (HP:0003458) | 1.88348507 |
| 134 | Osteomyelitis (HP:0002754) | 1.87983161 |
| 135 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87934320 |
| 136 | Easy fatigability (HP:0003388) | 1.87150828 |
| 137 | Capillary hemangiomas (HP:0005306) | 1.86681840 |
| 138 | Chest pain (HP:0100749) | 1.84127229 |
| 139 | Arterial tortuosity (HP:0005116) | 1.83987258 |
| 140 | Abnormality of T cell physiology (HP:0011840) | 1.83604519 |
| 141 | Hypoproteinemia (HP:0003075) | 1.83244736 |
| 142 | Stomatitis (HP:0010280) | 1.82992934 |
| 143 | Mediastinal lymphadenopathy (HP:0100721) | 1.82909507 |
| 144 | Alveolar cell carcinoma (HP:0006519) | 1.82314313 |
| 145 | Lipid accumulation in hepatocytes (HP:0006561) | 1.82044516 |
| 146 | Vertigo (HP:0002321) | 1.81285717 |
| 147 | Frequent falls (HP:0002359) | 1.81148231 |
| 148 | Acute hepatic failure (HP:0006554) | 1.80922756 |
| 149 | Cellulitis (HP:0100658) | 1.80458681 |
| 150 | Sepsis (HP:0100806) | 1.76527459 |
| 151 | Pustule (HP:0200039) | 1.76057466 |
| 152 | Increased IgM level (HP:0003496) | 1.75946510 |
| 153 | Joint swelling (HP:0001386) | 1.74941306 |
| 154 | Polyneuropathy (HP:0001271) | 1.71007168 |
| 155 | Toxemia of pregnancy (HP:0100603) | 1.67577225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMPR2 | 4.91336971 |
| 2 | TAOK3 | 4.83035409 |
| 3 | MAP3K6 | 3.84520508 |
| 4 | MOS | 2.91689143 |
| 5 | MUSK | 2.61952206 |
| 6 | IRAK4 | 2.47798835 |
| 7 | TXK | 2.46047992 |
| 8 | RIPK4 | 2.18705609 |
| 9 | CSK | 2.17537958 |
| 10 | MAP4K1 | 2.14571096 |
| 11 | ARAF | 2.01953519 |
| 12 | KIT | 2.01683754 |
| 13 | NLK | 1.95046548 |
| 14 | PRPF4B | 1.93193541 |
| 15 | MAP3K13 | 1.91357387 |
| 16 | CDK9 | 1.83505610 |
| 17 | PLK4 | 1.81768476 |
| 18 | CDK8 | 1.78346174 |
| 19 | TIE1 | 1.76540078 |
| 20 | GRK6 | 1.74491788 |
| 21 | TEC | 1.69852871 |
| 22 | FRK | 1.69478241 |
| 23 | ZAP70 | 1.68401731 |
| 24 | DMPK | 1.62112353 |
| 25 | JAK3 | 1.62006888 |
| 26 | MAP3K2 | 1.54319550 |
| 27 | RAF1 | 1.51885234 |
| 28 | EPHB1 | 1.49553870 |
| 29 | BRAF | 1.47479705 |
| 30 | LATS1 | 1.46302741 |
| 31 | TNK2 | 1.45126864 |
| 32 | HIPK2 | 1.42302158 |
| 33 | FGFR3 | 1.36649322 |
| 34 | DAPK2 | 1.32710525 |
| 35 | KSR2 | 1.27532028 |
| 36 | IKBKE | 1.27127077 |
| 37 | BTK | 1.26872418 |
| 38 | INSRR | 1.24252360 |
| 39 | MAP3K12 | 1.21148035 |
| 40 | PRKD2 | 1.20537199 |
| 41 | NEK9 | 1.19408230 |
| 42 | FGR | 1.18339021 |
| 43 | TYK2 | 1.15484032 |
| 44 | CAMKK2 | 1.14268991 |
| 45 | ACVR1B | 1.12275437 |
| 46 | SGK3 | 1.12268472 |
| 47 | TNIK | 1.08625338 |
| 48 | TBK1 | 1.06991934 |
| 49 | MAP3K3 | 1.04524736 |
| 50 | MAP2K6 | 1.04225544 |
| 51 | STK24 | 1.03349943 |
| 52 | SYK | 1.01671111 |
| 53 | STK11 | 1.01669421 |
| 54 | PINK1 | 1.00904617 |
| 55 | EPHA3 | 1.00791533 |
| 56 | MAP2K3 | 0.99627086 |
| 57 | MAPK12 | 0.96540019 |
| 58 | RIPK1 | 0.95291679 |
| 59 | MAPK13 | 0.94874238 |
| 60 | MAPKAPK5 | 0.94210825 |
| 61 | NUAK1 | 0.93293749 |
| 62 | MAPKAPK3 | 0.92461612 |
| 63 | PRKAA2 | 0.91515143 |
| 64 | EEF2K | 0.90063591 |
| 65 | GRK7 | 0.89916410 |
| 66 | TTN | 0.88677491 |
| 67 | PDK1 | 0.88400955 |
| 68 | TAOK1 | 0.87982253 |
| 69 | STK10 | 0.87869797 |
| 70 | MAP3K7 | 0.87278849 |
| 71 | ADRBK2 | 0.87270393 |
| 72 | TRPM7 | 0.86465177 |
| 73 | NTRK3 | 0.85179630 |
| 74 | MAP3K1 | 0.85043995 |
| 75 | CAMKK1 | 0.84643008 |
| 76 | KSR1 | 0.81802150 |
| 77 | CDK19 | 0.81112058 |
| 78 | MARK3 | 0.80968895 |
| 79 | SGK494 | 0.79998748 |
| 80 | SGK223 | 0.79998748 |
| 81 | ITK | 0.79883403 |
| 82 | CSNK1G1 | 0.79604370 |
| 83 | MAPK7 | 0.79074075 |
| 84 | ERN1 | 0.76528734 |
| 85 | CDK3 | 0.75763255 |
| 86 | MAP3K14 | 0.74119812 |
| 87 | MAP3K5 | 0.73694896 |
| 88 | PIM2 | 0.73625050 |
| 89 | TGFBR2 | 0.73225347 |
| 90 | MYLK | 0.71415516 |
| 91 | MAP2K4 | 0.70752223 |
| 92 | PTK2B | 0.70270228 |
| 93 | LCK | 0.69938178 |
| 94 | ERBB4 | 0.69646428 |
| 95 | JAK1 | 0.69307195 |
| 96 | GRK5 | 0.68778991 |
| 97 | CAMK4 | 0.68090593 |
| 98 | WNK1 | 0.67583601 |
| 99 | IRAK1 | 0.67485853 |
| 100 | PRKD3 | 0.64631126 |
| 101 | RET | 0.64373736 |
| 102 | STK38 | 0.63562639 |
| 103 | SGK1 | 0.63091555 |
| 104 | PAK3 | 0.62060174 |
| 105 | STK38L | 0.61561447 |
| 106 | BMPR1B | 0.60747274 |
| 107 | BLK | 0.60010361 |
| 108 | PIK3CA | 0.60010141 |
| 109 | SIK3 | 0.59189765 |
| 110 | OXSR1 | 0.58735782 |
| 111 | IRAK3 | 0.58693364 |
| 112 | PDPK1 | 0.57494266 |
| 113 | ABL1 | 0.57269624 |
| 114 | HCK | 0.56835096 |
| 115 | IRAK2 | 0.56725227 |
| 116 | CAMK1 | 0.56657017 |
| 117 | FYN | 0.55769402 |
| 118 | PHKG1 | 0.55556994 |
| 119 | PHKG2 | 0.55556994 |
| 120 | LYN | 0.55412508 |
| 121 | CAMK1G | 0.55243160 |
| 122 | MAP3K11 | 0.52809843 |
| 123 | CAMK1D | 0.52214134 |
| 124 | MAPK11 | 0.51791717 |
| 125 | OBSCN | 0.51718108 |
| 126 | MAP2K7 | 0.51435578 |
| 127 | MATK | 0.50788639 |
| 128 | FES | 0.49356583 |
| 129 | TTK | 0.46948954 |
| 130 | FGFR4 | 0.46363213 |
| 131 | PIK3CG | 0.46025526 |
| 132 | CHUK | 0.45840132 |
| 133 | PRKAA1 | 0.45757732 |
| 134 | STK3 | 0.45503801 |
| 135 | JAK2 | 0.45105967 |
| 136 | KDR | 0.44797470 |
| 137 | CSNK1G3 | 0.44235981 |
| 138 | LATS2 | 0.43148654 |
| 139 | PRKCQ | 0.42854486 |
| 140 | MARK2 | 0.42631761 |
| 141 | IKBKB | 0.42020086 |
| 142 | DYRK2 | 0.41141707 |
| 143 | YES1 | 0.39986241 |
| 144 | CSF1R | 0.36250986 |
| 145 | CSNK1G2 | 0.35699886 |
| 146 | ABL2 | 0.34590209 |
| 147 | SGK2 | 0.34133888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.33371534 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.13626856 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97019050 |
| 4 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.95624959 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94278335 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91131457 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90888183 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 1.79776576 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64933932 |
| 10 | RNA degradation_Homo sapiens_hsa03018 | 1.59538535 |
| 11 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55270726 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54353732 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54261797 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.53409197 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.51342134 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47349174 |
| 17 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.45216023 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.38985896 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37177214 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.36080013 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35168235 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.34566149 |
| 23 | Olfactory transduction_Homo sapiens_hsa04740 | 1.29740322 |
| 24 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.25934359 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.22536638 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.21604802 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19664661 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18602400 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.17498970 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17127009 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16235477 |
| 32 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.16002974 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14477555 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13916331 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12741695 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11148664 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11043796 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10694952 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.08756227 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08467203 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08175588 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03760990 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02202887 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.02083612 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00642634 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00501853 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.00381435 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98474978 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94736345 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94097356 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92638019 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92313272 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.91760254 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.91423854 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90749490 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90127122 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90043713 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 0.89932531 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88803666 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.87837643 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.87208640 |
| 62 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.85782661 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85134271 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84461238 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83739463 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82784203 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.81780533 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81111113 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.81108020 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80875793 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80681067 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80459703 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80456746 |
| 74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79974999 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79489925 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78678662 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.78578877 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77831965 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.74483587 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72252054 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72250649 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72058181 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71531497 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71422391 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71417326 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70263117 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68775796 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67890018 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.67622319 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67609300 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67197836 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67197327 |
| 93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.67172249 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67166202 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66773293 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66771018 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66573061 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.66054596 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65235527 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65108865 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64385762 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64199723 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.63219639 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61921854 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61770637 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61687609 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61195883 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58834247 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58362705 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57761176 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57467869 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57081378 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56570129 |
| 114 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56504257 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.56259729 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56030193 |
| 117 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55827542 |
| 118 | Insulin secretion_Homo sapiens_hsa04911 | 0.55739506 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.55356618 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.54278787 |
| 121 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54063478 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53446456 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.52893518 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52685418 |
| 125 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52240127 |
| 126 | Salivary secretion_Homo sapiens_hsa04970 | 0.52053345 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51042891 |
| 128 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49523541 |
| 129 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48534458 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48451722 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47577772 |
| 132 | Taste transduction_Homo sapiens_hsa04742 | 0.46307295 |
| 133 | Phagosome_Homo sapiens_hsa04145 | 0.45977346 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45854195 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45780106 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44934326 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44103065 |

